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BRIEF COMMUNICATION
DETECTION OF Cysticercus ANTIGENS AND ANTIBODIES IN CEREBROSPINAL FLUID OF PATIENTS
WITH CHRONIC MENINGITIS
Subhash Chandra PARIJA, Priyadarshi Soumyaranjan SAHU & Hariharkrishnaiear DHANYA
SUMMARY
Chronic meningitism is a less frequent manifestation of neurocysticercosis caused by Taenia solium cysticerci. In the present
study we used Co-agglutination (Co-A), a simple and rapid slide agglutination test to detect specific Cysticercus antigen in the 67
cerebrospinal fluid (CSF) samples from patients with chronic meningitis of unknown etiology. The results were compared with
that of ELISA for detection of antibodies. Among these samples four (5.97%) were positive for Cysticercus antigen by Co-A test
and six (8.95%) were positive for antibodies by ELISA. Two samples were positive by both Co-A and ELISA, two were positive
only by Co-A and four were positive only by ELISA. In the present study, although Cysticercus antigen and antibodies were
present in CSF samples from eight (11.94%) patients, we cannot affirm that all the cases of chronic meningitis are due to
cysticercosis, but for any case of chronic meningitis of unknown origin, it would be useful to consider the possibility of cysticercal
meningitis.
KEYWORDS: Chronic meningitis; Neurocysticercosis; Cerebrospinal fluid; Cysticercus antigen; Anti-Cysticercus antibodies;
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Neurocysticercosis (NCC) is one of the most common parasitic
diseases of the central nervous system prevalent worldwide. The
condition is caused by Cysticercus cellulosae, the metacestode larva
of Taenia solium. In most of the developing countries, NCC comprises
10% of acute neurologic cases7. Epilepsy is the usual presentation of
the condition. Other known presentations include raised intracranial
pressure, meningoencephalitis, focal neurological deficit and
psychiatric symptoms. Chronic meningitis is the chronic inflammation
of the meninges where characteristic neurologic syndromes exist for >
4 weeks and is associated with a persistent inflammatory response in
the cerebrospinal fluid. The entity of chronic meningitis as part of the
spectrum of NCC although observed to be rare in comparison to other
symptoms, nevertheless have been documented by several
authors8,14,15,24,25. Headache, vertigo, vomiting, papilloedema, an altered
level of consciousness, and gait disturbances may be present in patients
with meningitis caused by T. solium cysticerci21. Thus diagnosis of
NCC at the clinic is difficult because of variable clinical signs and
symptoms and imaging findings are usually inconclusive or of poor
specificity5. An EITB assay using lectin purified glycoprotein antigens
has been reported to be 100% specific and 98% sensitive for diagnosis
of NCC26. But the preparation of the antigen for the EITB assay is
costly as well as difficult to perform. Moreover, these diagnostic kits
need to be imported from the overseas. Hence there is necessity to
develop reliable and economical in-house serological test for diagnosis
of cysticercosis.
In the present study we used co-agglutination (Co-A), a simple
and rapid slide agglutination test to detect Cysticercus antigen and
ELISA to detect specific anti-Cysticercus antibodies in the
cerebrospinal fluid, to establish a diagnosis of chronic meningitis of
unknown etiology.
CSF samples collected from 67 patients with chronic meningitis
were processed at the Department of Microbiology, JIPMER Hospital,
Pondicherry. CSF samples from 12 patients with meningitis caused by
Hemophilus influenzae (two), Staphylococcus aureus (two),
Streptococcus sp. (two), Enterococcus faecalis (one), Acinetobacter
boumani (two), Pseudomonas sp. (two) and Cryptococcus neoformans
(one) were used as negative controls. The CSF samples were stored at
-20 0C before testing.
Hyperimmune serum against C. cellulosae whole cyst antigen (total
soluble protein antigen) was raised in white New Zealand rabbit in
divided doses with Freund’s complete adjuvant in the primary dose
and with incomplete adjuvant in the booster doses. The IgG fraction
from the immune serum was purified by precipitation with cold
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saturated ammonium sulphate by the method of GOTTSTEIN9 as cited
by DEVI & PARIJA6.
ELISA and Co-agglutination (Co-A) were performed to detect
specific Cysticercus antibodies and antigens, respectively, in the CSF
samples. The standard procedure as described by CROWTHER4 was
followed with some modifications. Briefly, polystyrene microtiter plates
(NUNC) were coated with the C. cellulosae whole cyst antigen (total
soluble protein antigen) at the concentration 1 µg/100 µL/well. The
non-specific binding sites were blocked by BSA (2%) in PBS 7.2.
Optimum dilution of sample and standard CSF (CSF of confirmed
positive patients) were prepared in sample dilution buffer (PBS 7.2
containing 0.05% Tween-20) at the dilution 1:50 and 100 µL of diluted
CSF was added in duplicate. Goat anti-human-IgG-HRP conjugated
secondary antibody (DAKO) was incubated at the dilution of 1:1000.
The plate development was done with freshly prepared substrate
solution (6 mg OPD in 10 mL of PBS pH 7.2 and 10 µL of 30% H2O2).
The reaction was stopped by adding 50 µL of 2N H2SO4 in each well.
Then the absorbance was read at 492 nm in an ELISA reader (TEKAN).
CSF dilution and the antigen concentration that gave OD492 value of
more than the cut-off (mean titre of negative CSF samples + 2 SD)
were considered as positive.
The co-agglutination (Co-A) test for antigen detection was
performed as per the procedure described by PARIJA & REDDY18.
Twenty four hours grown cells of Staphylococcus aureus (Cowan I
strain) bearing protein A (SAPA) cells were harvested into PBS pH 7.2
and centrifuged at 3000 X g for 10 minutes, followed by washing three
times with PBS pH 7.2 containing 0.05% sodium azide (NaN3). The
pellet was fixed in 10 volume of 1.5% formaldehyde in PBS 7.2 at
room temperature (RT) for 90 minutes, followed by washing three
times. Then the cells were resuspended to 10 volume of buffer
containing 0.05% NaN3 and heated for five minutes at 80 0C followed
by washing three times. Finally the cells were resuspended in PBS 7.2
containing 0.05% NaN3. 0.1 mL of purified hyperimmune serum anti-
C. cellulosae was added to 1 mL of 10% suspension of SAPA cells,
mixed well and left at RT for about 30 minutes followed by washing
two times. The cells were then resuspended to a concentration of 2%
cells in PBS 7.2 containing 0.1% NaN3 and these sensitized cells were
stored at 4 0C till use. In parallel formalin fixed SAPA cells were
incubated with normal saline instead of hyperimmune serum to get
unsensitized SAPA cells as control cells.
The test was performed on the glass slides, with two aliquots of
25 µL of CSF sample. An equal volume (25 µL) of sensitized SAPA
cell suspension was added to one aliquot and the same volume (25 µL)
of a 2% suspension of unsensitized SAPA cells was added to the other.
The slide was then rotated manually for two min and then observed. In
a positive Co-A test, the addition of sensitized SAPA cells to the test
CSF resulted in large visible clumps of cells within two min; in a
negative reaction, no visible clumping was observed. Agglutination
with the sensitized cells and not with the unsensitized cells was
considered to be a positive result.
In the positive control test, 10 µL of stock C. cellulosae total
soluble protein antigen (protein content 0.7 g/dL) was added to 90 µL
of PBS pH 7.2 (1:10) and then diluted two fold up to 1:1280 with
PBS pH 7.2. and taken as positive control. The visible clumping with
sensitized cells and no agglutination with unsensitized cells showed
valid test. The highest dilution of the antigen showing visible
agglutination with sensitized cells and no agglutination with
unsensitized cells was considered as the detection limit of the test.
In the negative control test, instead of antigen, saline was taken for
negative control test and there was no agglutination with either
sensitized or unsensitized cells.
A total of eight CSF samples were positive for either Cysticercus
antigen or antibodies by Co-A and ELISA, respectively. The results of
67 CSF samples tested by ELISA and Co-A are presented in the Table
1. The antigen detection limit of the Co-A test using the particular
batch of reagent preparation was found to be up to 0.27 µg.
The specific clinical diagnosis of chronic meningitis caused by
cysticercosis is difficult. It is observed that cysticercal meningitis often
mimics other forms of chronic meningitis15,25 where serial CSF
examination shows consistently raised protein, decreased glucose level
and pleocytosis. In addition to signs of meningeal irritation, increased
intracranial pressure due to inflammation, edema, or an obstructing
cyst may be present23.
Many reports of cysticercal aetiology of chronic meningitis have
been documented from various parts of the World. In a recent study,
meningitis was found to be a presenting symptom in 4.1% of NCC
patients examined in Dehra Dun, India27. In a 12-year period data
analysis of subacute to chronic meningitis cases from South India,
anti-mycobacterial antibodies and anti-Cysticercus antibodies were
found in 35.4% and 5.47% of the cases of NCC respectively2. NCC
presenting as chronic meningitis is also being reported from Italy12,
Brazil1, Portugal16, Korea3,28, and other endemic parts of the
World10,12,20,21.
Our present study showed that of 67 patients with chronic meningitis
of unknown origin 5.97% were positive by Co-A, whereas, 8.95% were
positive by ELISA. Among Co-A negative CSF samples, four were
positive by ELISA. The failure of detecting antigen in these CSF
samples could be due to the absence of antigen in the CSF, to antigen
concentration that were below detection limit of the assay or to
degradation of antigen during storage of CSF at -20 0C.
Serology of NCC may be resulting with apparently false positive
tests for several reasons: some healthy subjects residing in endemic
areas may have serum antibodies induced by previous infections that
Table 1
Comparison of Co-A and ELISA results obtained with CSF samples collected
from 67 patients with chronic meningitis of unknown origin
ELISA Co-A result
result No. (%) positive No. (%) negative Total (%)
Positive 2 (2.98) 4 (5.97) 6 (8.95)
Negative 2 (2.98) 59 (88.05) 61 (91.04)
Total 4 (5.97) 63 (94.02) 67 (100)
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did not progress to the establishment of cysticerci, or because they
bear cysticerci that are localized in clinically inconspicuous anatomic
sites22. Also a major cause of truly false positive serology in methods
using whole or partially purified antigen preparations is the extensive
sharing of antigenic epitopes of many cestodes and helminths13. But
the extent of cross-reacting antibody in CSF is supposed to be less
common than that in serum17,19.
In the present study, we cannot affirm that all the cases of chronic
meningitis are due to cysticercosis, but for any case of chronic
meningitis of unknown origin, it would be useful to consider the
possibility of cysticercal meningitis. This is important particularly in
the area where both tuberculosis and NCC are endemic and make the
clinical diagnosis of chronic meningitis most confusing. KATTI &
ACHAR11 have demonstrated both anti-mycobacterial and anti-
Cysticercus antibodies in 17.14% of CSF samples from patients with
chronic meningitis. Moreover, cysticercosis may be the underlying
etiology associated with chronic meningitis cases especially when other
infectious etiology is unknown.
RESUMO
Detecção de antígenos e anticorpos de Cysticercus em fluido
cerebrospinal de pacientes com meningite crônica
Meningite crônica é manifestação pouco freqüente de
neurocisticercose causada por cisticerco de Taenia solium.  No presente
estudo utilizamos co-aglutinação (Co-A) um teste simples e rápido de
aglutinação para detectar antígeno específico de Cysticercus nas 67
amostras de fluido cerebrospinal (CSF) de pacientes com meningite
crônica de etiologia desconhecida. Os resultados foram comparados
com os de ELISA para detecção de anticorpos. Dentre estas amostras
quatro (5,97%) foram positivas para antígenos de Cysticercus pelo teste
Co-A e seis (8,95%) foram positivas para anticorpos por ELISA. Duas
amostras foram positivas por ambos Co-A e ELISA, duas foram
positivas somente por Co-A e quatro foram positivas somente por
ELISA. No presente estudo embora antígenos e anticorpos de
Cysticercus estivessem presentes nas amostras de CSF de oito pacientes
(11,94%), não podemos afirmar que todos os casos de meningite crônica
sejam devidos à cisticercose, mas para qualquer caso de meningite
crônica de origem desconhecida seria útil considerar a possibilidade
de meningite por cisticerco.
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